Whereas the Community's legal framework for the protection of biotechnological inventions can be limited to laying down certain principles as they apply to the patentability of biological material as such, such principles being intended in particular to determine the difference between inventions and discoveries with regard to the patentability of certain elements of human origin, to the scope of protection conferred by a patent on a biotechnological invention, to the right to use a deposit mechanism in addition to written descriptions and lastly to the option of obtaining non-exclusive compulsory licences in respect of interdependence between plant varieties and inventions, and conversely;
Recital 13, Directive (EU) 1998/44
In forcesince 6 Jul 1998cited 1×
Judgment of the Court (Grand Chamber) of 6 July 2010. Monsanto Technology LLC v Cefetra BV and Others.Decision
Recitals 8 and 13 in the preamble to the Directive further state that: legal protection of biotechnological inventions does not necessitate the creation of a separate body of law in place of the rules of national patent law; the rules of …
6 Jul 2010 · 62008CJ0428